August 1, 2010The Oncologist281 citationsOpen Access
View Full PaperBevacizumab
Key Points
Key points are not available for this paper at this time.
Abstract
Abstract Learning Objectives After completing this course, the reader will be able to: Evaluate the clinical use of bevacizumab, both for cancer and for non-oncologic diseases, and discuss approved and investigational combination chemotherapies that include bevacizumab.Describe the pharmacology of bevacizumab and its mechanism of action in order to predict degrees of patient response. CME This article is available for continuing medical education credit at CME.TheOncologist.com.